Barclays
NUVA

Barclays’s NuVasive, Inc. NUVA Stock Holding History

Barclays’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100,000
Closed -$4.8M – 6717
2016
Q1 		$4.8M Buy
+100,000
New +$4.54M 0.01% 1209

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Barclays's NUVA Position: Q3 2023 in Review

Barclays sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 127,283 shares — an estimated $5.29M sold.

Barclays first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $60.3M in Q4 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Barclays reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Barclays sold 127,283 NuVasive, Inc. shares in Q3 2023, an estimated $5.29M.
  • Barclays first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Barclays's NuVasive, Inc. position peaked at $60.3M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.